Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Endod ; 39(5): 643-7, 2013 May.
Artigo em Inglês | MEDLINE | ID: mdl-23611383

RESUMO

INTRODUCTION: This study evaluated the development of periapical lesions in a rat model of type 2 diabetes and assessed the potential actions of the antioxidant agent tempol in this model. METHODS: Male Wistar rats were used; they received tap water (N = 5) or a 20% glucose solution (N = 15) during a period of 9 weeks. At the sixth week, periapical lesions were induced on the first mandibular molars, and the animals were subdivided into 4 groups. The subgroup 1 was composed of nondiabetic rats orally receiving saline solution (10 mL/kg). Chronically glucose-fed rats were divided into the following subgroups: (2) saline-treated animals (10 mL/kg by oral route), and animals treated with tempol by gavage at doses of (3) 50 mg/kg or (4) 100 mg/kg. The body weight was monitored thoroughly. After 21 days of apical periodontitis induction, the animals were killed, and the mandibles were collected and submitted to radiographic and histologic analysis. The livers were collected to determine free radicals, and the blood plasma was used to measure insulin levels. RESULTS: Type 2 diabetic rats displayed a significant decrease of body weight gain and a slight increase of insulin levels, which were allied to reduced levels of the antioxidant components catalase and reduced glutathione; these alterations were reversed by tempol. Concerning the periapical lesions, neither radiographic nor histologic analysis revealed any significant difference between control and type 2 diabetic rats. In diabetic rats, the apical periodontitis was refractory to tempol treatment. CONCLUSIONS: The extent and cellularity of periapical lesions in glucose-fed type 2 diabetic rats were similar to those seen in control rats. Despite affecting other parameters related to diabetes, tempol failed to improve the outcome of endodontic lesions in type 2 diabetic animals.


Assuntos
Antioxidantes/uso terapêutico , Diabetes Mellitus Experimental/tratamento farmacológico , Diabetes Mellitus Tipo 2/tratamento farmacológico , Periodontite Periapical/fisiopatologia , Animais , Antioxidantes/administração & dosagem , Peso Corporal , Catalase/análise , Catalase/efeitos dos fármacos , Óxidos N-Cíclicos/administração & dosagem , Óxidos N-Cíclicos/uso terapêutico , Modelos Animais de Doenças , Radicais Livres/análise , Glutationa/análise , Glutationa/efeitos dos fármacos , Insulina/sangue , Resistência à Insulina/fisiologia , Fígado/metabolismo , Masculino , Mandíbula/diagnóstico por imagem , Mandíbula/patologia , Dente Molar/diagnóstico por imagem , Dente Molar/patologia , Estresse Oxidativo/fisiologia , Periodontite Periapical/diagnóstico por imagem , Periodontite Periapical/patologia , Radiografia , Ratos , Ratos Wistar , Marcadores de Spin , Resultado do Tratamento
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...